Stock 300255 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Equities

300255

CNE1000016C2

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
11.49 CNY -3.12% Intraday chart for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. -1.54% -11.68%
Apr. 28 Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 14 Yang Minghuan completed the acquisition of 5.8% stake in Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from Gao Shuhua. CI

Business Summary

Hebei Changshan Biochemical Pharmaceutical Co., Ltd is principally engaged in the research, development, manufacture and distribution of bio-pharmaceutical products. The Company primarily provides heparin product series. The Company provides sodium heparin active pharmaceutical ingredients (APIs) and hydro-acupuncture preparations. The Company's products are applied primarily in the prevention and treatment of cerebral vascular diseases, hardened arteries, myocardial infarction and phlebitis, among others. It distributes its products in domestic and overseas markets.

Number of employees: 1,424

Sales per Business

CNY in Million2022Weight2023Weight Delta
Low Molecular Weight Heparin Preparations
55.3 %
1,206 51.6 % 779 55.3 % -35.35%
Unfractionated Heparin Active Pharmaceutical Ingredients
23.7 %
597 25.5 % 335 23.7 % -43.90%
Others
9.6 %
63 2.7 % 136 9.6 % +114.42%
Low Molecular Weight Heparin Active Pharmaceutical Ingredients
7.8 %
435 18.6 % 110 7.8 % -74.68%
Unfractionated Heparin Preparations
3.6 %
36 1.5 % 50 3.6 % +41.53%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
85.2 %
1,704 72.9 % 1,202 85.2 % -29.48%
Foreign
14.8 %
632 27.1 % 209 14.8 % -66.98%

Managers

Managers TitleAgeSince
Jun Wang DFI
 Director of Finance/CFO 47 09-08-31
Zheng Gang Qie BRD
 Director/Board Member 53 20-06-23
Yun Xia Sun BRD
 Director/Board Member 43 21-05-19
Xiao Dong Gao BRD
 Director/Board Member 51 06-08-31
Rong Guo Bai IRC
 Investor Relations Contact - -
Zhong Ying Liu SEC
 Corporate Secretary 47 21-08-26

Members of the board

Members of the board TitleAgeSince
Xiang Jun Wang BRD
 Director/Board Member 60 21-12-29
Yan Bin Liu BRD
 Director/Board Member 62 09-04-30
De Ying Cao BRD
 Director/Board Member 65 -
Xiao Dong Gao BRD
 Director/Board Member 51 06-08-31
Yan Na Deng BRD
 Director/Board Member 50 00-08-31
Jin Liang Wang BRD
 Director/Board Member 58 99-03-31
Shu Xuan Gao CHM
 Chairman 47 18-12-27
Yun Xia Sun BRD
 Director/Board Member 43 21-05-19
Zheng Gang Qie BRD
 Director/Board Member 53 20-06-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 919,060,878 383,292,832 ( 41.70 %) 0 41.70 %

Shareholders

NameEquities%Valuation
Shu Hua Gao
35.81 %
333,644,728 35.81 % 528 M ¥
China State-Owned Assets Supervision & Admn Commission
6.805 %
63,403,020 6.805 % 100 M ¥
Hebei Huaxu Chemical Co. Ltd.
2.432 %
22,659,500 2.432 % 36 M ¥
Xi Chen
1.453 %
13,533,065 1.453 % 21 M ¥
Hui Liu
1.326 %
12,356,828 1.326 % 20 M ¥
Du Chen
0.8265 %
7,700,000 0.8265 % 12 M ¥
Ming Zhu
0.7835 %
7,300,000 0.7835 % 12 M ¥
Ming Shun Tao
0.7698 %
7,171,963 0.7698 % 11 M ¥
Jin Ming Mao
0.5982 %
5,573,110 0.5982 % 9 M ¥
China Merchants Fund Management Co., Ltd.
0.3985 %
3,712,400 0.3985 % 6 M ¥

Company contact information

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

71 Menglong Street Zhengding High-Tech Indl Dev Zone

050800, Shijiazhuang

+86 311 8919 0181

http://hbcsbio.com
address Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(300255)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. Stock Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
-11.68% 1.46B
CSL LIMITED Stock CSL Limited
-2.61% 89.08B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.55% 40.9B
BIOGEN INC. Stock Biogen Inc.
-14.40% 32.25B
UCB Stock UCB
+55.89% 25.14B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-15.96% 15.39B
INCYTE CORPORATION Stock Incyte Corporation
-15.50% 11.91B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-41.29% 11.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.75% 11.64B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+7.87% 9.03B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300255 Stock
  4. Company Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW